Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 31;12(10):e0185686.
doi: 10.1371/journal.pone.0185686. eCollection 2017.

Development of an interstitial cystitis risk score for bladder permeability

Laura E Lamb  1   2 , Joseph J Janicki  3 , Sarah N Bartolone  1 , Kenneth M Peters  1   2 , Michael B Chancellor  1   2
Affiliations

Development of an interstitial cystitis risk score for bladder permeability

Laura E Lamb et al. PLoS One. .

Abstract

Background: Interstitial cystitis/bladder pain syndrome (IC) is a multifactorial syndrome of severe pelvic and genitalia pain and compromised urinary function; a subset of IC patients present with Hunner's lesions or ulcers on their bladder walls (UIC). UIC is diagnosed by cystoscopy, which may be quite painful. The objective of this study was to determine if a calculated Bladder Permeability Defect Risk Score (BP-RS) based on non-invasive urinary cytokines could discriminate UIC patients from controls and IC patients without Hunner's ulcers.

Methods: A national crowdsourcing effort targeted IC patients and age-matched controls to provide urine samples. Urinary cytokine levels for GRO, IL-6, and IL-8 were determined using a Luminex assay.

Results: We collected 448 urine samples from 46 states consisting of 153 IC patients (147 female, 6 male), of which 54 UIC patients (50 females, 4 male), 159 female controls, and 136 male controls. A defined BP-RS was calculated to classify UIC, or a bladder permeability defect etiology, with 89% validity.

Conclusions: The BP-RS Score quantifies UIC risk, indicative of a bladder permeability defect etiology in a subset of IC patients. The Bladder Permeability Defect Risk Score is the first validated urine biomarker assay for interstitial cystitis/bladder pain syndrome.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: LEL, JJJ, and MBC have intellectual property associated with methods for diagnosing interstitial cystitis. All other authors have declared no conflicts of interest exist. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Consolidated standards of reporting trials flow diagram for study numbers.
UIC = IC with Hunner’s lesions; NUIC = IC without Hunner’s lesions.
Fig 2
Fig 2. Urinary cytokine levels by group.
A) Mean and SEM values for urine cytokines GRO, IL-6, and IL-8. B-G) Urinary levels of cytokines GRO, IL-6, and IL-8 in groups Control and NUIC compared to UIC (B-D) or control compared to NUIC compared to UIC (E-F). Error bars are SEM. Statistical differences were determined using Mann-Whitney test (B-G) or Kruskal-Wallis ANOVA (E-G). * indicates p<0.05, ** indicates p<0.01, *** indicates p<0.001, **** indicates p<0.0001.
Fig 3
Fig 3. Average BP-RS probabilities in IP4IC training set and of P3 validation set.
The BP-RS is a score that gives the probability that a patient has UIC. Each of the validation data points were fed into the trained Random Forest Classifier (RFC), and the BP-RS (probability of UIC) was calculated and plotted for each patient. The bars on the boxes describe the minimum and maximum points, and the horizontal lines of the box show the 25%, 50% (median), and 75% quartiles. Points outside of the bars are outliers. The individual probabilities are also plotted (black points). Because we used a binary classifier, all of the points above 0.5 (dotted line) are predicted to have UIC, and all points below are classified as control or NUIC. In the validation set, two patients from each of the control and NUIC groups were incorrectly classified as having UIC, and two points from the UIC group were incorrectly classified as not having UIC.
Fig 4
Fig 4. Receiver operating characteristic (ROC) curves.
ROC curves for the IP4IC (training set) and P3 (validation set) using the BP-RS. The AUC for the IP4IC dataset = 0.971 and P3 dataset = 0.919.
See this image and copyright information in PMC

References

    1. Clemens JQ, Mullins C, Kusek JW, Kirkali Z, Mayer EA, Rodriguez LV, et al. The MAPP research network: a novel study of urologic chronic pelvic pain syndromes. BMC urology. 2014;14:57 doi: 10.1186/1471-2490-14-57 ; PubMed Central PMCID: PMC4134515. - DOI - PMC - PubMed
    1. Berry SH, Elliott MN, Suttorp M, Bogart LM, Stoto MA, Eggers P, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540–4. doi: 10.1016/j.juro.2011.03.132 ; PubMed Central PMCID: PMCPMC3513327. - DOI - PMC - PubMed
    1. Daniels NA, Link CL, Barry MJ, McKinlay JB. Association between past urinary tract infections and current symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome. J Natl Med Assoc. 2007;99(5):509–16. ; PubMed Central PMCID: PMCPMC2576075. - PMC - PubMed
    1. Suskind AM, Berry SH, Ewing BA, Elliott MN, Suttorp MJ, Clemens JQ. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study. The Journal of urology. 2013;189(1):141–5. doi: 10.1016/j.juro.2012.08.088 ; PubMed Central PMCID: PMC3894747. - DOI - PMC - PubMed
    1. Hurst RE, Meerveld BG, Wisniewski AB, VanGordon S, Lin H, Kropp BP, et al. Increased bladder permeability in interstitial cystitis/painful bladder syndrome. Transl Androl Urol. 2015;4(5):563–71. doi: 10.3978/j.issn.2223-4683.2015.10.03 ; PubMed Central PMCID: PMCPMC4706376. - DOI - PMC - PubMed

Publication types